Anti-inflammatory, cancer drugs tested in UK as possible COVID-19 therapy

LONDON - Two drugs used to treat inflammatory diseases and cancer are being tested as potential therapies for patients with COVID-19, the Universities of Birmingham and Oxford announced on Wednesday.

Izana Bioscience's Namilumab, a monoclonal antibody already in late-stage tests to treat rheumatoid arthritis and an inflammatory disease called ankylosing spondylitis, is the first of 4 candidates in the CATALYST trial. Ben Fisher, trial co-clinical investigator from the University of Birmingham, said: "Emerging evidence is demonstrating a critical role for anti-inflammatory drugs in the cytokine storm associated with severe COVID-19 infection.

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

No face-to-face classes until anti-Covid vaccine becomes availableDepEd Secretary Leonor Briones said the department will heed President Rodrigo Duterte’s directive to not allow students to physically go back to school until a vaccine is available. Read the story:
Source: sunstaronline - 🏆 18. / 59 Read more »